FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today!

About | Sample | Privacy

DC passes pharma rep licensing bill

Tools

Soon, pharma sales folk could be ticketed for repping without a license. The District of Columbia's governing council voted to require sales reps to obtain licenses, becoming the only jurisdiction in the country to do so.

The vote was close--seven to six. And the final measure lacked a provision that would have prohibited data-mining of doctors' prescribing habits. Nevertheless, the primary provision stands. Once licensed, reps could be suspended for fraudulent behavior.

- read the article in the Washington Post
- here's more from the Washington Business Journal

Related Articles:
DC to vote on rep-licensing bill. Report
Dr. Drug Rep tells all. Report
Top Lilly exec plays secret sales agent. Report

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 19 + 23?
To combat spam, please solve the math question above.